Showing posts with label colds. Show all posts
Showing posts with label colds. Show all posts

Wednesday, April 09, 2014

Coughs and sneezes staying airborne

Cold and flu pathogens may stay airborne for long
distances after a sneeze or a cough, researchers say.
The next time you feel a sneeze coming on, raise your elbow to cover up that multiphase turbulent buoyant cloud you're about to expel.

That's right: A novel study by MIT researchers shows that coughs and sneezes have associated gas clouds that keep their potentially infectious droplets aloft over much greater distances than previously realized.

"When you cough or sneeze, you see the droplets, or feel them if someone sneezes on you," says John Bush, a professor of applied mathematics at MIT, and co-author of a new paper on the subject.

"But you don't see the cloud, the invisible gas phase. The influence of this gas cloud is to extend the range of the individual droplets, particularly the small ones."

Indeed, the study finds, the smaller droplets that emerge in a cough or sneeze may travel five to 200 times further than they would if those droplets simply moved as groups of unconnected particles � which is what previous estimates had assumed.

The tendency of these droplets to stay airborne, resuspended by gas clouds, means that ventilation systems may be more prone to transmitting potentially infectious particles than had been suspected.

With this in mind, architects and engineers may want to re-examine the design of workplaces and hospitals, or air circulation on airplanes, to reduce the chances of airborne pathogens being transmitted among people.

"You can have ventilation contamination in a much more direct way than we would have expected originally," says Lydia Bourouiba, an assistant professor in MIT's Department of Civil and Environmental Engineering, and another co-author of the study.

The paper, "Violent expiratory events: on coughing and sneezing," was published in the Journal of Fluid Mechanics.

It is co-written by Bourouiba, Bush, and Eline Dehandschoewercker, a graduate student at ESPCI ParisTech, a French technical university, who previously was a visiting summer student at MIT, supported by the MIT-France program.

Smaller drops, longer distances

The researchers used high-speed imaging of coughs and sneezes, as well as laboratory simulations and mathematical modeling, to produce a new analysis of coughs and sneezes from a fluid-mechanics perspective.

Their conclusions upend some prior thinking on the subject. For instance: Researchers had previously assumed that larger mucus droplets fly farther than smaller ones, because they have more momentum, classically defined as mass times velocity.

That would be true if the trajectory of each droplet were unconnected to those around it. But close observations show this is not the case; the interactions of the droplets with the gas cloud make all the difference in their trajectories. Indeed, the cough or sneeze resembles, say, a puff emerging from a smokestack.

A cough or sneeze is a "multiphase turbulent buoyant cloud," as the researchers term it in the paper, because the cloud mixes with surrounding air before its payload of liquid droplets falls out, evaporates into solid residues, or both.

"The cloud entrains ambient air into it and continues to grow and mix," Bourouiba says. "But as the cloud grows, it slows down, and so is less able to suspend the droplets within it. You thus cannot model this as isolated droplets moving ballistically."

The MIT researchers are now developing additional tools and studies to extend our knowledge of the subject. For instance, given air conditions in any setting, researchers can better estimate the reach of a given expelled pathogen.

Source: EurekAlert! 

Good indoor air quality is essential to your health and well-being. Remove airborne contaminants such as chemicals, odors, particles, dust, allergens, mold, bacteria and viruses with an industrial-strength air purifier by AllerAir. The activated carbon and HEPA air filters remove the widest range of contaminants. UV germicidal filtration is also available. Contact AllerAir for more information and a free consultation.

Monday, January 21, 2013

Asthma researchers make breakthrough in attacks related to colds and allergens

Pediatric and respiratory researchers from the University of Newcastle, along with national and international collaborators, are a step closer to identifying the source of serious virus-and allergen-induced asthma attacks after detecting important molecular signals generated very early in the disease process.

Led by Professor Joerg Mattes, the team of researchers and clinicians spent several years investigating the mechanisms that trigger airway inflammation and cause asthma attacks.

The pre-clinical study targeted the common cold (rhinovirus), which is the virus that causes most asthma attacks; and the effects caused by allergens such as house dust mites.

“Asthmatics experience severe and prolonged symptoms when infected with the common cold virus or exposed to allergens, both of which promote inflammation in the lungs and production of mucus," Professor Mattes said.

“Asthma attacks are currently treated similarly regardless of whether they are caused by viruses or allergens. However virus-induced effects are much less responsive to current therapies, which is why this investigation is so important.”

A comprehensive gene expression analysis led to the initial discovery of the signals – proteins otherwise known as midline 1 and protein phosphatase 2A.

“The proteins are generated in the innermost layer of the airways, where the body has first contact with allergens and viruses, and once activated they appear to modulate many other disease factors,” Dr Adam Collison**, one of the study authors from Professor Mattes’ research team, said. “Obviously it is better to target these earlier signals rather than the hundreds of downstream effects.”

The researchers have already begun testing therapeutic strategies to modify the pathway, setting a platform for the development of targeted drugs ahead of full clinical trialling.

“We have seen that this pathway operates in the cells of asthmatics, and our pre-clinical disease models showed that we can inhibit the pathway and protect against the development of both virus- and allergen-induced asthma,” Professor Mattes said.

He advised sufferers to be vigilant with their asthma management during late summer and winter, the worst times for cold epidemics.

The results are published in Nature Medicine, the world’s leading journal for biomedical research. Researchers from the University of New South Wales, the University of Cincinnati and the Imperial College London took part in the investigation. 

Tuesday, September 27, 2011

Study shows the high costs of colds in North America

The cost of colds and the flu weighs heavily on Canadian
and US workers, a new study shows.
A Canadian study on the impact of colds and flu on school absenteeism, the workplace and the economy found that the costs are staggering.

In the first study of its kind, the researchers reviewed published clinical trials, studies and research projects from more than 300 researchers. 

The report with the title "Why the Common Cold and Flu Matter" pointed out the following highlights.
  • 1/3 of Canadian adults have a sore throat, cold or flu in any given month. More common in women than men.  
  • 2/3 of Canadian adults experiencing the first signs of a cold or flu used some type of self-treatment. Women were more likely to self treat and also consult a doctor as compared to men.  
  • 1/5 of Canadian adults ignore symptoms altogether  
  • Cough/cold remedies are the second most commonly used medications in Canada.  
  • Canadians spend more than $300 million a year on over-the-counter cold and flu treatments and prescription antibiotics which, for the most part, neither "...ameliorate symptoms nor change the course of the illnesses."

The researchers say prevention can make a big difference in reducing the impact of colds and the flu.

While children in schools and daycare easily spread infections and colds, adults are also to blame, the study found, as many continue to go to work when they are sick and the spreading diseases lead to much greater productivity losses and increased costs for companies.

In fact, 83% of participants in a U.S. survey on work and illness say they continued to attend work or school while experiencing symptoms of an influenza-like illness. 

This behavior adds up to a significant economic cost as researchers cite direct costs due to lost productivity from colds at $25 billion in the U.S. 

Taking into consideration both indirect (lost productivity) and direct (doctor visits and medicine) costs, of colds, the figure in the U.S. annually is $40 billion.

Improve IAQ at home and at work for better results

Air purifiers for the home and office:
4000, 5000 and 6000 Series
AllerAir’s carbon + HEPA airpurifiers provide a simple and cost-effective solution to better indoor air at home, in school and at the office.

Choose an air purifier with UV germicidal filtration (like a 5000 Exec UV) for enhanced protection from biological contaminants such as viruses, bacteria and mold mycotoxins.

The powerful air purifiers are easy to use, portable and effective in removing a wide range of indoor air pollutants, including chemicals, VOCs, gases, fumes, odors, particles, pollen, dust and pathogens.

Contact AllerAir for more information and personalized recommendations.